Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04380051Recruiting
Sensory touch therapy to help parents bond with very preterm babies
This study tests whether a gentle sensory “stimulation” approach can improve how parents and very preterm babies interact and support the baby’s social development. If you qualify, you and your baby would be asked to take part so researchers can see whether this early intervention helps bonding and social skills.
ReimsAges Up to 1 day - NCT04390737RecruitingPhase 1/Phase 2
Study drug HH2853 for hard-to-treat lymphoma and solid cancers
This Phase 1/2 trial tests the safety and early effectiveness of HH2853 in people whose cancer has come back or did not respond to prior treatment. It may help shrink tumors and guide future treatment for specific cancer types and genetic changes.
Phoenix, ArizonaAges 18 years+ - NCT04451044Enrolling by invitation
Guided heart stent planning using an inside pressure sensor
This study tests whether using a tiny pressure sensor in heart arteries during a procedure can better guide where to place a stent. It may help doctors choose the safest and most effective stent plan by more accurately measuring artery narrowing.
Birmingham, AlabamaAges 18 years+ - NCT02714764Recruiting
Testing how best to measure outcomes in Alexander disease
This study is looking at which measurements best capture changes over time in people with Alexander disease. It may help researchers and doctors track the disease more accurately in future care and studies.
Philadelphia, PennsylvaniaAges Any age - NCT04308278RecruitingPhase 4
Homeopathic treatment for Epstein-Barr virus fatigue
This study tests a homeopathic treatment (2LEBV® and 2LXFS®) for people with Epstein-Barr virus infection who experience long-lasting fatigue and other symptoms. It aims to see if this treatment helps reduce fatigue and improve overall well-being.
Heule, KortrijkAges 12 years+ - NCT04279496Enrolling by invitation
CT heart scan registry to track outcomes over time
This is a research registry that follows people who are already getting a CT scan of their heart arteries for medical reasons. It aims to better understand how these scans relate to future heart outcomes, while collecting follow-up health information.
Charlottesville, VirginiaAges 18 years+ - NCT04271488RecruitingPhase 1
Study drug levels in people with mild or moderate liver problems
This Phase 1 study measures how tasurgratinib (E7090) and its breakdown product move through the body in people with mild or moderate liver impairment. It aims to understand appropriate dosing and safety considerations for liver impairment.
Hakata, FukuokaAges 20–79 - NCT04300556RecruitingPhase 1/Phase 2
Testing an antibody-drug for advanced certain cancers
This early-phase trial tests a treatment called MORAb-202, an antibody “delivery” drug, to see if it’s safe and can help shrink or control certain advanced cancers. It may help people whose tumors match the study’s specific cancer types and prior treatment history.
Tucson, ArizonaAges 18 years+ - NCT04342910RecruitingPhase 3
Test camrelizumab plus apatinib for advanced stomach cancer
This trial studies whether combining camrelizumab (an immunotherapy) and apatinib (a targeted pill) can control advanced, unresectable stomach or gastroesophageal junction cancer that has grown after first treatment. It also looks at how safe the combination is.
BeijingAges 18 years+ - NCT04348318Recruiting
Evaluating an advance care plan for ICU patients
This study looks at how well advance care planning documents are put into action for people who stay in the intensive care unit (ICU). If you participated, it may help the hospital improve how patients’ wishes are followed during serious illness.
AarauAges 18 years+ - NCT04357574Enrolling by invitation
Testing a radiation treatment decision system during COVID-19 changes
This trial looks at whether a computer system can help guide high-intensity radiation treatment decisions when care has been disrupted during COVID-19. It may help improve how treatment is planned and adjusted during times when patients’ situations change.
Durham, North CarolinaAges 18 years+ - NCT04373473RecruitingPhase 2
Oral stool treatment to prevent ulcerative colitis flare-ups
This study tests whether taking freeze-dried (lyophilized) donor stool material by mouth can help prevent ulcerative colitis from coming back or causing intestinal inflammation. Participants are in remission and stay on their usual treatment while receiving the study product.
Houston, TexasAges 18 years+ - NCT04263792RecruitingPhase 1
Scan trial to track a new tracer in suspected bacterial infections
This Phase 1 study uses a special scan tracer ([18F]F-TMP) to see how it moves in the body and how fast it changes in people with suspected or known bacterial infections. It’s mainly testing the scan’s behavior and safety, which may help future infection-targeting imaging.
Philadelphia, PennsylvaniaAges 18 years+ - NCT04355572Recruiting
Vitamin D replacement study for teens at risk of PCOS
This study looks at how taking vitamin D affects hormone levels and emotional well-being in teen girls who may develop PCOS. If you have low vitamin D and meet PCOS risk criteria, the study may test whether vitamin D helps you feel and function better.
New Haven, ConnecticutAges 13–21 - NCT04371900Recruiting
Study children of mothers using birth control access in Michigan
This study looks at children ages 0 to 17 whose mothers took part in a Michigan program to access birth control. Researchers will track child and family outcomes to understand how improving access to contraception can affect families.
Ann Arbor, MichiganAges birth–17 years - NCT04374916Recruiting
Predicting preterm birth for threatened early labor
This study tests a new way to predict if you are likely to give birth early, using a simple test when you show signs of early labor. It aims to help doctors decide who really needs treatment and who can be reassured.
StrasbourgAges 18 years+ - NCT04262206RecruitingPhase 4
Testing how statins affect outcomes in adults 75 and older
This trial studies whether cholesterol-lowering medicine (a statin, specifically atorvastatin) improves health and benefits in people age 75 and older in everyday life. It may help doctors understand which older adults benefit most and how to use these medicines safely.
Birmingham, AlabamaAges 75 years+ - NCT04158180Recruiting
Questionnaire study for diastasis recti in adult women
This trial is testing and verifying a Spanish questionnaire about diastasis recti (a separation in the abdominal muscles). It may help by creating a tool that doctors and researchers can use to better understand symptoms and severity.
Plasencia, CáceresAges 18–65 - NCT04188522Recruiting
MEG study of memory after a small stroke
This study uses a special brain scan called MEG to understand how thinking and memory change after a small ischemic stroke. If you qualify, you may get scanned about 4–6 weeks after your stroke and help researchers learn what brain signals relate to recovery.
Baltimore, MarylandAges 18–100 - NCT04228211Recruiting
Research study for people newly diagnosed with prostate cancer
This study follows people with newly diagnosed prostate cancer to understand care decisions and outcomes over the long term. It uses routine medical information and asks you to complete questionnaires, which may help improve future treatment and support.
Nieuwegein, UtrechtAges 18 years+ - NCT04157361Recruiting
Non-invasive lung testing in asthma and cystic fibrosis
This trial studies how well a non-invasive lung test can show lung involvement in people with asthma (especially IgE-related asthma) and people with cystic fibrosis. You might benefit by getting extra lung assessments without invasive procedures.
OlomoucAges Any age - NCT04192955RecruitingPhase 3
Aspirin before and after brain aneurysm coiling
This trial tests if taking aspirin before and after a procedure to fix an unruptured brain aneurysm (coiling) helps prevent complications. Aspirin is a common blood thinner that might reduce the risk of blood clots or other problems after the procedure.
Calgary, AlbertaAges 18 years+ - NCT04194996Recruiting
Study of surgery for crooked or bent neck alignment
This study looks at how well planned surgery corrects neck (cervical) deformities and how the results change over time. It mainly involves standard pre- and follow-up imaging and study questionnaires to compare clinical and X-ray outcomes.
La Jolla, CaliforniaAges 18 years+ - NCT04165486RecruitingPhase 1
Test drug safety in adults with multiple system atrophy
This Phase 1 study checks how safe a drug called ION464 is, how the body handles it, and how much of the drug reaches the bloodstream in adults with multiple system atrophy (MSA). It may help researchers find a dosing approach for future treatments for MSA.
InnsbruckAges 40–70
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.